Judge: Investor Failed To Show Statements About Cancer Treatment Were Misleading
NEW YORK — A federal judge in New York granted a biotechnology company’s motion to dismiss a putative class complaint brought against it by an investor who accused it of misleading...To view the full article, register now.
Already a subscriber? Click here to view full article